thelancet.com
Jun 12, 2025, 05:36
The Lancet Haematology – Extended Anticoagulation in Children with VTE: New Insights from the EINSTEIN-Jr Trial
The Lancet Haematology shared on X:
“A cohort study within the EINSTEIN-Jr trial explores extended-phase anticoagulation for acute VTE in children:
Key factors: symptomatic index VTE, unprovoked VTE, & residual thrombosis.
Low risk of recurrent VTE & no major bleeding.”
Title: Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.
Autors: Christoph Male, Anthonie W A Lensing, Anthony K C Chan, Gili Kenet, Guy Young, Rukhmi Bhat, Akos F Pap, Dagmar Kubitza, Martin H Prins, Paul Monagle.
Here are some of the most compelling recent updates on Hemostasis Today
Akos F Pap
Anthonie W A Lensing
Anthony K C Chan
Anticoagulation Safety
Bleeding Risk in Children
Christoph Male
Dagmar Kubitza
EINSTEIN-Jr Trial
Extended-phase Anticoagulation
Gili Kenet
Guy Young
Headlines
Hemostasis Today
Martin H Prins
Paul Monagle
Pediatric Hemostasis
Pediatric Venous Thromboembolism
Recurrent Thrombosis Risk
Residual Thrombosis
Rukhmi Bhat
Symptomatic VTE
The Lancet Haematology
Unprovoked VTE in Children
-
Dec 19, 2025, 06:13Anna Aldehag Reflects on Her 12 Year Leadership in Sweden National Board of Health and Welfare
-
Dec 19, 2025, 05:54Abdul Mannan: APTT Mixing Studies Confuse a Lot of People
-
Dec 18, 2025, 23:14The “Normal” FVIII Level Trap in Females with Haemophilia
-
Dec 18, 2025, 23:11WFH Expands Multidisciplinary Bleeding Disorder Training in Vietnam
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals